Work

Gemcitabine and oxaliplatin (GEMOX) alone or in combination with cetuximab as first-line treatment for advanced biliary cancer: Final analysis of a randomized phase II trial (BINGO).

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.4032

Authors: David Malka, Laetitia Fartoux, Vanessa Rousseau, Tanja Trarbach, Eveline Boucher, Christelle De La Fouchardiere, Sandrine J. Faivre, Frédéric Viret, Jean-Frédéric Blanc, Eric Assenat, Pascal Hammel, Christophe Louvet, Goetz von Wichert, Michel Ducreux, Olivier Rosmorduc, Jean-Pierre Pignon, Tim F Greten

Institutions: Institut Gustave Roussy, Hôpital Saint-Antoine, Centre Eugène Marquis, Centre Léon Bérard, Hôpital Beaujon, Institut Paoli-Calmettes, Hôpital Saint-André, Universität Ulm, Medizinische Hochschule Hannover

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2949169644

Cites:

Cited by: 23

Related to: 10